NCT02580552 · Interventional trial
Safety, Tolerability and Pharmacokinetics of MRG-106 in Patients With Mycosis Fungoides (MF), CLL, DLBCL or ATLL
Overall registry status Completed
Phase 1
Conditions Adult T-Cell Leukemia/Lymphoma (ATLL), Chronic Lymphocytic Leukemia (CLL), Cutaneous T-cell Lymphoma (CTCL), Diffuse Large B-Cell Lymphoma (DLBCL), ABC Subtype, Mycosis Fungoides (MF)
Delaware Valley sites
- Thomas Jefferson University Hospital · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory